About
Corporate Overview
Founders
Management
Scientific Advisory Board
Board of Directors
Board of Advisors
Partnerships
Pleadings
Videos
ACP Testimonials
CEO Updates
News
Technology
Technology Overview
Manufacturing
Intellectual Property
Publications
Clinical Pipeline
ACP-01 Phase II Clinical Trial for CLI
CLI Phase II Trial Summary
Platform
Critical Limb Ischemia
Investors
Investor Overview
A Three Minute Summary
Public Filings
AGM Materials
News & Media
News / Press Releases
Contact
MENU ≡
About
Corporate Overview
Founders
Management
Scientific Advisory Board
Board of Directors
Board of Advisors
Partnerships
Pleadings
Videos
ACP Testimonials
CEO Updates
News
Technology
Technology Overview
Manufacturing
Intellectual Property
Publications
Clinical Pipeline
ACP-01 Phase II Clinical Trial for CLI
CLI Phase II Trial Summary
Platform
Critical Limb Ischemia
Investors
Investor Overview
A Three Minute Summary
Public Filings
AGM Materials
News & Media
News / Press Releases
Contact
News & Media
all
2020
2019
2018
2017
2016
2015
2014
Nov 26
/ 2014
Hemostemix and Technical Ventures Complete RTO Transaction
Oct 02
/ 2014
Theravitae Inc. Announces Leadership Transition
Jun 25
/ 2014
Hemostemix Advances Clinical Trial Preparation
May 05
/ 2014
Hemostemix Joins Centre for Commercialization of Regenerative Medicine, Industry Consortium
Apr 22
/ 2014
Hemostemix Announces its Second US Patent
